RTI Surgical Inc. (RTIX) Stock Rating Upgraded by Zacks Investment Research
RTI Surgical Inc. (NASDAQ:RTIX) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report issued on Wednesday.
According to Zacks, “RTI Surgical Inc. is a surgical implant company. Its implants are used in sports medicine, general surgery, spine, orthopedic, trauma and cardiothoracic procedures. RTI Surgical Inc., formerly known as RTI Biologics, Inc., is headquartered in Alachua, Fla. “
Separately, Craig Hallum cut shares of RTI Surgical from a “buy” rating to a “hold” rating and decreased their target price for the stock from $6.00 to $4.00 in a report on Thursday, July 28th.
Shares of RTI Surgical (NASDAQ:RTIX) opened at 3.06 on Wednesday. RTI Surgical has a 52-week low of $2.81 and a 52-week high of $5.74. The stock has a 50 day moving average of $3.20 and a 200 day moving average of $3.65. The firm has a market cap of $176.78 million, a price-to-earnings ratio of 43.10 and a beta of 1.44.
RTI Surgical (NASDAQ:RTIX) last announced its earnings results on Wednesday, July 27th. The company reported ($0.05) EPS for the quarter, missing the consensus estimate of $0.03 by $0.08. RTI Surgical had a return on equity of 6.51% and a net margin of 2.80%. The firm earned $67.60 million during the quarter, compared to analyst estimates of $66.52 million. During the same quarter in the previous year, the business earned $0.04 earnings per share. The business’s quarterly revenue was down 5.6% compared to the same quarter last year. Equities analysts predict that RTI Surgical will post $0.10 EPS for the current fiscal year.
Hedge funds have recently bought and sold shares of the company. Metropolitan Life Insurance Co. NY boosted its stake in RTI Surgical by 1.9% in the first quarter. Metropolitan Life Insurance Co. NY now owns 42,735 shares of the company’s stock valued at $171,000 after buying an additional 783 shares in the last quarter. Analytic Investors LLC raised its position in shares of RTI Surgical by 0.7% in the second quarter. Analytic Investors LLC now owns 215,927 shares of the company’s stock valued at $775,000 after buying an additional 1,492 shares during the last quarter. Alliancebernstein L.P. raised its position in shares of RTI Surgical by 4.6% in the second quarter. Alliancebernstein L.P. now owns 59,049 shares of the company’s stock valued at $212,000 after buying an additional 2,600 shares during the last quarter. Ancora Advisors LLC raised its position in shares of RTI Surgical by 1.4% in the second quarter. Ancora Advisors LLC now owns 211,000 shares of the company’s stock valued at $757,000 after buying an additional 3,000 shares during the last quarter. Finally, Numeric Investors LLC raised its position in shares of RTI Surgical by 14.0% in the second quarter. Numeric Investors LLC now owns 68,196 shares of the company’s stock valued at $245,000 after buying an additional 8,400 shares during the last quarter. Institutional investors and hedge funds own 78.97% of the company’s stock.
RTI Surgical Company Profile
RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.
Receive News & Stock Ratings for RTI Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical Inc. and related stocks with our FREE daily email newsletter.